Nightmare-Enacting Behavior Responding to Zonisamide in Early Parkinson's Disease

Recently, zonisamide (ZNS) has been approved as a new adjunctive therapy for motor complications of Parkinson's disease (PD). More recently, ZNS was reported to be effective for the management of impulse control behavior in PD, suggesting potential effects on non-motor PD symptoms. Dream enactm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataoka, Hiroshi, Ueno, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published: January, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335357/
https://www.ncbi.nlm.nih.gov/pubmed/22545035
http://dx.doi.org/10.1159/000336441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335357/
https://www.ncbi.nlm.nih.gov/pubmed/22545035
http://dx.doi.org/10.1159/000336441

Ejemplares similares